Literature DB >> 10067852

E-box and cyclic adenosine monophosphate response elements are both required for follicle-stimulating hormone-induced transferrin promoter activation in Sertoli cells.

J Chaudhary1, M K Skinner.   

Abstract

Sertoli cells are the epithelial cells responsible for the onset of pubertal development and maintenance of spermatogenesis in the adult. Transferrin is one of the major secretory products expressed by differentiated Sertoli cells. Investigation of the transcriptional control of transferrin gene expression provides insight into the regulation of Sertoli cell differentiation. Analysis of the mouse transferrin (mTf) promoter reveals the presence of a number of conserved response elements that have previously been shown to regulate cell specific expression of the human transferrin (hTf) promoter. One of these elements is the human PRII region, which is a cAMP response element (CRE)-like element that is more than 80% conserved in the mTf promoter. The activation of the hTf promoter by FSH and cAMP in rat Sertoli cells has been shown to be mediated in part through the CRE-like PRII region and binding of the CRE binding protein (CREB). The present study investigates the role of PRII in the activation of mTf promoter by FSH and cAMP in rat Sertoli cells. Mutations in the PRII of the mTf promoter reduced FSH activation by only 50% and cAMP activation by more than 90%. In contrast, the mutant PRII mTf promoter construct was fully activated by a partially purified testicular paracrine activity PModS(S300). Gel shift experiments demonstrated that proteins that can bind a consensus CRE oligonucleotide also bind the PRII region of the mTf promoter. An immunoblot confirmed that CREB binds the PRII and promotes the gel shift observed. The hypothesis developed was that another cis-acting element in addition to the CRE-like PRII is also involved in FSH actions. A conserved response element in both the mTf and hTf promoters is the basic helix-loop-helix (bHLH) responsive E-box sequence. Both FSH and PModS (S300) activity were found to promote a mTf E-box gel shift that contained the E2A gene product the bHLH protein E47. Interestingly, mutations in the E-box of the mTf promoter completely abolished the PModS(S300) activation and partially (52%) inhibited the activation by FSH. In contrast, the mutant E-box mTf promoter construct was fully activated by cAMP. Finally a double mutation of both the PRII and the E-box completely abolished FSH activation of the mTf promoter. These results suggest that optimal activation of the mouse transferrin promoter by FSH requires both CREB binding to the CRE-like PRII region and bHLH binding to the E-box. Information is provided that indicates a number of Sertoli cell promoters contain a close association of E-box and CRE-like elements. Observations are discussed in regards to the potential interactions of the CRE and E-box response elements in mediating FSH actions in Sertoli cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067852     DOI: 10.1210/endo.140.3.6597

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  16 in total

1.  Structure and expression of the human p68 RNA helicase gene.

Authors:  O G Rössler; P Hloch; N Schütz; T Weitzenegger; H Stahl
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Integration of CREB and bHLH transcriptional signaling pathways through direct heterodimerization of the proteins: role in muscle and testis development.

Authors:  Tera Muir; Jeanne Wilson-Rawls; Jeffrey D Stevens; Alan Rawls; Ronen Schweitzer; Chulhee Kang; Michael K Skinner
Journal:  Mol Reprod Dev       Date:  2008-11       Impact factor: 2.609

3.  Different signal transduction pathways elicited by basic fibroblast growth factor and interleukin 1β regulate CREB phosphorylation in Sertoli cells.

Authors:  M N Galardo; M F Riera; M Regueira; E H Pellizzari; S B Cigorraga; S B Meroni
Journal:  J Endocrinol Invest       Date:  2012-08-29       Impact factor: 4.256

4.  SRY directly regulates the neurotrophin 3 promoter during male sex determination and testis development in rats.

Authors:  Tracy M Clement; Ramji K Bhandari; Ingrid Sadler-Riggleman; Michael K Skinner
Journal:  Biol Reprod       Date:  2011-04-20       Impact factor: 4.285

5.  SRY induced TCF21 genome-wide targets and cascade of bHLH factors during Sertoli cell differentiation and male sex determination in rats.

Authors:  Ramji K Bhandari; Ellyn N Schinke; Md M Haque; Ingrid Sadler-Riggleman; Michael K Skinner
Journal:  Biol Reprod       Date:  2012-12-06       Impact factor: 4.285

6.  USF1/2 transcription factor DNA-binding activity is induced during rat Sertoli cell differentiation.

Authors:  Michelle A Wood; William H Walker
Journal:  Biol Reprod       Date:  2008-09-03       Impact factor: 4.285

7.  Testosterone activates mitogen-activated protein kinase and the cAMP response element binding protein transcription factor in Sertoli cells.

Authors:  Charity Fix; Cynthia Jordan; Patricia Cano; William H Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

8.  GATA factors and androgen receptor collaborate to transcriptionally activate the Rhox5 homeobox gene in Sertoli cells.

Authors:  Anjana Bhardwaj; Manjeet K Rao; Ramneet Kaur; Miriam R Buttigieg; Miles F Wilkinson
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

9.  Differential control of seed primary dormancy in Arabidopsis ecotypes by the transcription factor SPATULA.

Authors:  Fabián E Vaistij; Yinbo Gan; Steven Penfield; Alison D Gilday; Anuja Dave; Zhesi He; Eve-Marie Josse; Giltsu Choi; Karen J Halliday; Ian A Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

10.  Lentiviral transduction of rat Sertoli cells as a means to modify gene expression.

Authors:  Peter K Nicholls; Peter G Stanton; Katarzyna E Rainczuk; Hongwei Qian; Paul Gregorevic; Craig A Harrison
Journal:  Spermatogenesis       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.